| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | gamma-catenin binding | 1.63e-04 | 12 | 32 | 2 | GO:0045295 | |
| GeneOntologyCellularComponent | F-actin capping protein complex | 7.61e-05 | 9 | 31 | 2 | GO:0008290 | |
| HumanPheno | Allergy | 5.59e-05 | 41 | 10 | 3 | HP:0012393 | |
| Domain | MYT1 | 8.52e-06 | 3 | 32 | 2 | PF08474 | |
| Domain | Myelin_TF | 8.52e-06 | 3 | 32 | 2 | IPR013681 | |
| Domain | F-actin_cap_A | 8.52e-06 | 3 | 32 | 2 | PF01267 | |
| Domain | CapZ_alpha | 8.52e-06 | 3 | 32 | 2 | IPR002189 | |
| Domain | F-actin_cap_asu_CS | 8.52e-06 | 3 | 32 | 2 | IPR017865 | |
| Domain | F_ACTIN_CAPPING_A_1 | 8.52e-06 | 3 | 32 | 2 | PS00748 | |
| Domain | F_ACTIN_CAPPING_A_2 | 8.52e-06 | 3 | 32 | 2 | PS00749 | |
| Domain | Znf_C2HC | 4.25e-05 | 6 | 32 | 2 | IPR002515 | |
| Domain | zf-C2HC | 4.25e-05 | 6 | 32 | 2 | PF01530 | |
| Domain | ZF_CCHHC | 5.94e-05 | 7 | 32 | 2 | PS51802 | |
| Domain | Cadherin_C | 8.32e-04 | 25 | 32 | 2 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 8.32e-04 | 25 | 32 | 2 | IPR000233 | |
| Domain | Catenin_binding_dom | 1.12e-03 | 29 | 32 | 2 | IPR027397 | |
| Domain | - | 1.12e-03 | 29 | 32 | 2 | 4.10.900.10 | |
| Domain | p53-like_TF_DNA-bd | 3.71e-03 | 53 | 32 | 2 | IPR008967 | |
| Domain | Ig_E-set | 1.37e-02 | 104 | 32 | 2 | IPR014756 | |
| Domain | Cadherin_CS | 1.49e-02 | 109 | 32 | 2 | IPR020894 | |
| Domain | Cadherin | 1.60e-02 | 113 | 32 | 2 | PF00028 | |
| Domain | CADHERIN_1 | 1.60e-02 | 113 | 32 | 2 | PS00232 | |
| Domain | CADHERIN_2 | 1.63e-02 | 114 | 32 | 2 | PS50268 | |
| Domain | - | 1.63e-02 | 114 | 32 | 2 | 2.60.40.60 | |
| Domain | CA | 1.65e-02 | 115 | 32 | 2 | SM00112 | |
| Domain | Cadherin-like | 1.68e-02 | 116 | 32 | 2 | IPR015919 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 8.46e-05 | 134 | 25 | 4 | M27751 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.09e-04 | 53 | 25 | 3 | M27651 | |
| Pathway | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | 2.33e-04 | 13 | 25 | 2 | M975 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 4.17e-04 | 203 | 25 | 4 | M27654 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 17060446 | ||
| Pubmed | Vertebrates have conserved capping protein alpha isoforms with specific expression patterns. | 2.46e-06 | 3 | 32 | 2 | 9331217 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 29656931 | ||
| Pubmed | LRRTMs Organize Synapses through Differential Engagement of Neurexin and PTPσ. | 2.46e-06 | 3 | 32 | 2 | 31995730 | |
| Pubmed | Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12. | 2.46e-06 | 3 | 32 | 2 | 12470955 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 34796874 | ||
| Pubmed | 4.17e-06 | 1442 | 32 | 9 | 35575683 | ||
| Pubmed | Myt/NZF family transcription factors regulate neuronal differentiation of P19 cells. | 4.92e-06 | 4 | 32 | 2 | 21540077 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 7665558 | ||
| Pubmed | Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin. | 4.92e-06 | 4 | 32 | 2 | 30361697 | |
| Pubmed | Mammalian CARMIL inhibits actin filament capping by capping protein. | 4.92e-06 | 4 | 32 | 2 | 16054028 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 7894164 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 24214099 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 7959727 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 8786128 | ||
| Pubmed | Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. | 3.26e-05 | 67 | 32 | 3 | 29863498 | |
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 15850461 | ||
| Pubmed | Mapping of the mouse actin capping protein alpha subunit genes and pseudogenes. | 4.49e-05 | 11 | 32 | 2 | 9119363 | |
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 25624497 | ||
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 16973135 | ||
| Pubmed | KEAP1 Mutations Drive Tumorigenesis by Suppressing SOX9 Ubiquitination and Degradation. | 5.38e-05 | 12 | 32 | 2 | 33173725 | |
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 19515692 | ||
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 17928203 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 1.12e-04 | 1242 | 32 | 7 | 30973865 | |
| Pubmed | 1.38e-04 | 1285 | 32 | 7 | 35914814 | ||
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 18723693 | ||
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 1.70e-04 | 21 | 32 | 2 | 25249183 | |
| Pubmed | 1.70e-04 | 21 | 32 | 2 | 30021842 | ||
| Pubmed | Sp9 Regulates Medial Ganglionic Eminence-Derived Cortical Interneuron Development. | 2.24e-04 | 24 | 32 | 2 | 29878134 | |
| Pubmed | The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85. | 2.24e-04 | 24 | 32 | 2 | 21822214 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 2.73e-04 | 1005 | 32 | 6 | 19615732 | |
| Pubmed | 4.22e-04 | 159 | 32 | 3 | 30581152 | ||
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 4.38e-04 | 161 | 32 | 3 | 32572027 | |
| Pubmed | 4.62e-04 | 164 | 32 | 3 | 32409323 | ||
| Pubmed | 5.65e-04 | 38 | 32 | 2 | 29321139 | ||
| Pubmed | Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons. | 6.26e-04 | 40 | 32 | 2 | 27657450 | |
| Pubmed | HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress. | 6.58e-04 | 41 | 32 | 2 | 24614889 | |
| Pubmed | 7.23e-04 | 43 | 32 | 2 | 20876399 | ||
| Pubmed | 7.46e-04 | 1215 | 32 | 6 | 15146197 | ||
| Pubmed | 7.92e-04 | 45 | 32 | 2 | 22114352 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q12 | 2.41e-03 | 104 | 32 | 2 | chr18q12 | |
| GeneFamily | Zinc fingers C2H2C-type | 3.49e-06 | 3 | 20 | 2 | 1261 | |
| GeneFamily | RNA binding motif containing | 2.28e-02 | 213 | 20 | 2 | 725 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.17e-05 | 97 | 31 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.05e-06 | 127 | 32 | 4 | ace2944328529fa029ee56c7ad3b0f283511d3bb | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.97e-06 | 150 | 32 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.00e-06 | 159 | 32 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 167 | 32 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.36e-06 | 169 | 32 | 4 | 606aa4ff25380d9470ec116ca86cd20f8b19587a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.36e-06 | 169 | 32 | 4 | 052aae2af5446a0de071d5dda5381b0b9a0ed54d | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.67e-06 | 171 | 32 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 131 | 32 | 3 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-basal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 132 | 32 | 3 | cac8c38a398f0185c68bf5b88053010e30475236 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 139 | 32 | 3 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.40e-04 | 141 | 32 | 3 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-04 | 148 | 32 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.68e-04 | 150 | 32 | 3 | f4aed24b79e1be38abc7a1120256821601893d6d | |
| ToppCell | COPD-Epithelial-PNEC|COPD / Disease state, Lineage and Cell class | 1.99e-04 | 159 | 32 | 3 | 6018124980c55190928409f3bf41d846a118954a | |
| ToppCell | COPD-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 2.03e-04 | 160 | 32 | 3 | cdea93317b0ebb801ddbe73bca6149ce2c727f16 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.14e-04 | 163 | 32 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-04 | 168 | 32 | 3 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.38e-04 | 169 | 32 | 3 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 170 | 32 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-04 | 171 | 32 | 3 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-04 | 172 | 32 | 3 | 3f894c74916d49a995b2d4651ca1c6733c14ce9c | |
| ToppCell | Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, Lineage and Cell Type | 2.55e-04 | 173 | 32 | 3 | f88269327441858ddb8c49b9dd619b76fd53b1da | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 176 | 32 | 3 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-04 | 176 | 32 | 3 | aab9603b7943b7f7243eb6190ebba998566196f3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 176 | 32 | 3 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.73e-04 | 177 | 32 | 3 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 2.82e-04 | 179 | 32 | 3 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 181 | 32 | 3 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.91e-04 | 181 | 32 | 3 | 7e12030965881b023f0d3d27d934fa648e2cc523 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.96e-04 | 182 | 32 | 3 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.96e-04 | 182 | 32 | 3 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.96e-04 | 182 | 32 | 3 | fa23d5bed1147a423c42bd30029a06963410b16e | |
| ToppCell | wk_15-18-Epithelial-PNS-Early_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 183 | 32 | 3 | 7e8366ec8117d36cec67f77dcb0e9a6032d87fcb | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.16e-04 | 186 | 32 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.16e-04 | 186 | 32 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-04 | 187 | 32 | 3 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-04 | 187 | 32 | 3 | 85645de9069bd9a8a02d53b0d3d73bf9c2b57189 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 188 | 32 | 3 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | 006db2c2c44971ca9241c582bc89f258c785f5ed | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | d0e6fb4a3b3d79d3512b5500062ea285495ae526 | |
| ToppCell | wk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.26e-04 | 188 | 32 | 3 | d3d7d21d4fa39ac4106a164652673de1bef8662d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.31e-04 | 189 | 32 | 3 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.31e-04 | 189 | 32 | 3 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.41e-04 | 191 | 32 | 3 | 5b6e1caf7827ee4e1f39ca25f04ebbf608952721 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.41e-04 | 191 | 32 | 3 | 146cfd4daa2878536b4f381564c787919ad855a8 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.41e-04 | 191 | 32 | 3 | 12ea07565dc0e62cade9fbab4a2d763e47a341e3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-04 | 192 | 32 | 3 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.46e-04 | 192 | 32 | 3 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.46e-04 | 192 | 32 | 3 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 193 | 32 | 3 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 193 | 32 | 3 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 193 | 32 | 3 | 8851275bcf4ecd6e87a91c8784fc5d76d246ff3b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-04 | 193 | 32 | 3 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.52e-04 | 193 | 32 | 3 | 25b1e5a04724023918c8939109a92b35582d5e5c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 194 | 32 | 3 | 4e93bd903cddfd0c8f220b6a35b449895de4119b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 194 | 32 | 3 | 15224fb3e7ca5bd1fb8c41f8275842f737014095 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-04 | 195 | 32 | 3 | b25c534fc6320d4da6437ef1b27e32a5d5256f3e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 196 | 32 | 3 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-04 | 196 | 32 | 3 | eea354bdaf4c558df6a94ec4f2f817f7073821d9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-04 | 197 | 32 | 3 | 1018aac22659c081d227d566afa29b1748c18ade | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-04 | 197 | 32 | 3 | 8951787ed1f7ac1772a6ef0ba2dd44c51fd3c47b | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-04 | 197 | 32 | 3 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 198 | 32 | 3 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 198 | 32 | 3 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | 328f1d5d8168e05edd301d3a0f2eb5c6cd1c67c8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | 6e314dc820db9c53fe7fc7c96bed4d7d9a325160 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | 6483d412b6c0aab58b3348f99231caa5daf65025 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | dac7b68bb8f1c4d8aa7fdfada61f79956866e874 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 199 | 32 | 3 | 47466253069d4b1b8f13ce3210f434e60753b38a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 199 | 32 | 3 | f2410509007d35e948a88f127f613d0119e6a4c4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 199 | 32 | 3 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-OPC_related|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | b19a75d4f23e9685cbb6c6fa873d7726f27bd5f2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_1(GAD1)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 6c16151567ef100296f7c12cde350fc6ce146745 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_1(GAD1)-GLP1R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 7da0ccfcd024842ad85f34b523ead6ec61f7e864 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_1(GAD1)-GLP1R--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | cdc43730334f8f623d936469acbae00a67c13a7b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_1(GAD1)-GLP1R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 6b1c0176fe2ec6baedae44a7b330c2b32eea25cb | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-OPC_related-Oligodendrocyte/OPC|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | b99dc49b735430a5ac51159575b904020d861927 | |
| Disease | Abnormality of the eye | 2.24e-05 | 7 | 31 | 2 | C4316870 | |
| Disease | Attention deficit hyperactivity disorder | 2.91e-04 | 24 | 31 | 2 | C1263846 | |
| Disease | diastolic blood pressure, unipolar depression | 4.56e-04 | 30 | 31 | 2 | EFO_0003761, EFO_0006336 | |
| Disease | word list delayed recall measurement, memory performance | 5.53e-04 | 33 | 31 | 2 | EFO_0004874, EFO_0006805 | |
| Disease | atopic eczema, psoriasis | 6.58e-04 | 36 | 31 | 2 | EFO_0000274, EFO_0000676 | |
| Disease | response to xenobiotic stimulus | 9.14e-04 | 182 | 31 | 3 | GO_0009410 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.22e-03 | 49 | 31 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | tuberculosis | 1.49e-03 | 216 | 31 | 3 | MONDO_0018076 | |
| Disease | susceptibility to mononucleosis measurement | 2.40e-03 | 69 | 31 | 2 | EFO_0008403 | |
| Disease | TNF-related apoptosis-inducing ligand measurement | 2.61e-03 | 72 | 31 | 2 | EFO_0008300 | |
| Disease | post-traumatic stress disorder symptom measurement | 3.37e-03 | 82 | 31 | 2 | EFO_0008535 | |
| Disease | initial pursuit acceleration | 3.78e-03 | 87 | 31 | 2 | EFO_0008434 | |
| Disease | hypertension | 4.04e-03 | 307 | 31 | 3 | EFO_0000537 | |
| Disease | refractive error | 4.78e-03 | 326 | 31 | 3 | MONDO_0004892 | |
| Disease | spontaneous preterm birth | 5.06e-03 | 101 | 31 | 2 | EFO_0006917 | |
| Disease | S-7-hydroxywarfarin measurement | 5.97e-03 | 110 | 31 | 2 | EFO_0803329 | |
| Disease | Beta blocking agent use measurement | 6.39e-03 | 114 | 31 | 2 | EFO_0009929 | |
| Disease | risk-taking behaviour | 8.05e-03 | 764 | 31 | 4 | EFO_0008579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITYSAMQVYNEENPE | 146 | Q8IWT0 | |
| NNETPNRVMLDYYRQ | 526 | Q96G01 | |
| NMTQTIYSQLQEEYE | 226 | Q9H7T0 | |
| ENEYQTAISENYQTM | 236 | P52907 | |
| YYTQNMEREISNSDG | 116 | Q9NW64 | |
| ASESSEQDYYSNMRQ | 196 | Q8IUH3 | |
| NPTYLDMDYQVQIQE | 271 | Q8N543 | |
| EEYRNSMPASSFQQQ | 171 | Q9NQ29 | |
| RESERQMNSPLQEYY | 471 | Q86VH4 | |
| TSDYENIPAMNSDYE | 771 | Q6ZNL6 | |
| MNEVYTNQPTGDYFT | 361 | Q9H4K1 | |
| DVNDNIPYMEQSSYT | 261 | Q02413 | |
| SQRNYMVQTEDQYSF | 1626 | Q13332 | |
| MNNISVPQEDDYGYQ | 391 | Q8N1C3 | |
| AQDPDRYMQQNIRYT | 521 | P19022 | |
| RDYMERDKENPNQYN | 896 | Q13620 | |
| YRDTMLDSYENTVPQ | 61 | Q6ZNG9 | |
| TPMEQQDEYSENYIL | 1036 | Q5VU65 | |
| NQMENNEERYTPLDY | 516 | Q9Y283 | |
| MENLSSNRFYSQPEQ | 666 | Q7Z2Y5 | |
| VSSEVNFNYEYAQME | 581 | Q9NQT8 | |
| RNYEIIQQPMSYDNL | 246 | P08842 | |
| SNMDQEYGTAYTPQT | 966 | Q9UHV7 | |
| QPEEYMAYVQRQADS | 251 | Q13438 | |
| EQNFEAYVNTLTDMY | 1006 | O60284 | |
| SMSNQEKQPYYEEQA | 661 | P35712 | |
| ENEYQTAISENYQTM | 236 | P47755 | |
| VPSYEEVMNTNYSEA | 131 | Q9NW97 | |
| TDNNRTYPSIQIMNY | 41 | Q04864 | |
| LDSEPQRQEYVMNDY | 151 | O43548 | |
| QTYLNTMESYDPQTN | 711 | Q9NR64 | |
| TEMYTNQDRYQSPEN | 1156 | Q9UL68 |